Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees

Journal of Medical Primatology

Volumn 30, Issue 5, 2001, Pages 243-253

  Ondoa, Pascale ^a   Kestens, Luc ^a   Davis, David ^a   Vereecken, Chris ^a   Willems, Betty ^a   Fransen, Katrien ^a   Vingerhoets, Johan ^a   Zissis, Georges ^b   Haaft, Peter Ten ^c   Heeney, Jonathan ^c   Van Groen, Guido Der ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Animal models of lentivirus infection; Cell mediated immunity

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CHIMPANZEE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXICITY; DISEASE COURSE; DISEASE RESISTANCE; FOLLOW UP; HEALTH STATUS; HUMAN IMMUNODEFICIENCY VIRUS; HYPOTHESIS; IMMUNE DEFICIENCY; IN VITRO STUDY; LONG TERM CARE; LONGITUDINAL STUDY; MEASUREMENT; NONHUMAN; PERIPHERAL LYMPHOCYTE; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TIME; VIRUS CULTURE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; PAN (APE); PAN TROGLODYTES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0035213921     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0684.2001.d01-56.x     Document Type: Article

References (66)

1. Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy
2. HIV suppression by interleukine-16
3. Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capturing assay
4. Potent HIV-1 inhibiting soluble factor from chimpanzee peripheral blood cells
5. Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants
6. Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors
7. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry
8. Correlates of protection in HIV infection and the protection of HIV infection to AIDS
9. Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive Factors produced byCD8+ T cells
10. Dynamics of HIV-1 mRNA expression in patients with long term non-progressive HIV-1 infection
11. Longitudinal study of plasma HIV infection measured using AMPLICOR HIV monitor and NASBA HIV-1 RNA QT tests
12. Identification of a major co-receptor for primary isolates of HIV-1
13. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genetyope and the clinical course of HIV-1 infection
14. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patient
15. Non-Progression in HIV-1 infection
16. Long term non-progression in HIV infection: Methodological issues and scientific priorities
17. Natural killer cells from HIV-1 + patients produce C-C chemokines and inhibit HIV-1 infection
18. Perspective on the role of CD8 + cells suppressor factors and cytotoxic T lymphocytes during HIV infection
19. 6/l
20. Differences in HIV replication in CD4 + lymphocytes are not related to β-chemokines production
21. Inhibition of human immunodeficiency virus (HIV) replication by CD8 + T lymphocytes from macaques immunized with live attenuated SIV
22. The resistance- of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction
23. AIDS: A disease of impaired T-helper (Th)-cell renewal?
24. Transmission of SIVcpz and kinetics of infection in the presence and absence of concurrent HIV-1 infection in chimpanzees
25. Quantification of human immunodeficiency virus type 1 in the blood of infected persons
26. Concentrations of circulating β-chemokines do not correlate with viral loads in human immunodeficiency virus-infected individuals
27. In vitro suppression of SIVcpz is suppressed by CD8 + T cells but not by NK cells of chimpanzees
28. SIVcpz-ant causes a non-escalating immune activation and uses multiple co-receptors in chimpanzees (abstract No. 11210)
29. Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection
30. Equivalent recognition of HIV protein, Env, gag and pol by CD4 + and CD8 + cytotoxic T-lymphocytes
31. An activated CD8 + T cell phenotype correlates with anti HIV activity and asymptomatic clinical status
32. Controlling HIV pathogenesis: The role of the non-cytotoxic anti-HIV response of CD8 + T cells
33. A CD4 + cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24.: Cytotoxic activity and secretion of IL-2 and IL-3
34. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
35. CD8 + cell anti HIV activity: Non-lytic suppression of virus replication
36. CD8 + cells anti-HIV activity correlates with the clinical state of the infected individuals
37. Serum chemokine levels in patients with non-progressing HIV infection
38. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1
39. Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant
40. Role of class I major histocompatibility complex-restricted and -unrestricted suppression of human immunodeficiency virus type 1 replication by CD8 + T lymphocytes
41. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vivo
42. Induction of CD4 + human cytolytic T cells specific for HIV-infected cells by a gp 160 subunit vaccine
43. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals
44. Inhibition of HIV-1 infection by the β-chemokine MDC
45. Studies in long-term nonprogressive human immunodeficiency virus infection
46. Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee
47. Virologic and serologic characteristics of a natural chimpanzee lentivirus infection
48. HIV-1 RNA levels and the development of clinical disease
49. Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection
50. Human immunodeficiency virus type 1 infection of antigen-specific CD4 cytotoxic T lymphocytes
51. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
52. Control of viremia in simian immunodeficiency virus infection by CD8 + lymphocytes
53. A critical site in the core of the CCR5 chemokine receptor required for binding and and infectivity of human immunodeficiency virus type 1
54. Effect of different donor cells on human immunodeficiency virus type-1 replication and selection in vitro
55. Comparison of culture and non culture-based methods for quantification of viral load and resistance to antiretroviral drugs in patients given zidovudine monotherapy
56. Virus load in chimpanzees infected with human immunodeficiency virus type 1: Effect of pre-exposure vaccination
57. A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques
58. Differences in early virus loads with different phenotypic variants of HIV-1 and SIVcpz in chimpanzees
59. Intact CCR5 co-receptors in HIV-1 infected chimpanzees
60. Specific antimononuclear phagocyte monoclonals antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages
61. Stability in controlling viral replication identifies Long-Term Nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons
62. Immune and hematopoietic parameters in HIV-1 infected chimpanzees during clinical progression toward AIDS
63. CD8 + lymphocytes can control HIV infection in vitro by suppressing virus replication
64. Inhibition of human immunodeficiency virus replication in acutely infected CD4 + cells by CD8 + cells involves a non-cytolytic mechanism
65. Suppression of human immunodeficiency type 1 replication by CD8 + cells: Evidence for HLA class I restricted triggering of cytolytic and non-cytolytic mechanisms
66. CD8 + cells in HIV infection produce macrophage inflammatory protein-1 alpha and RANTES: A comparative study in long-term survivors and progressor patients